Warfarin Anticoagulation in Patients in Sub-Saharan Africa

CompletedOBSERVATIONAL
Enrollment

681

Participants

Timeline

Start Date

June 11, 2018

Primary Completion Date

February 29, 2024

Study Completion Date

July 29, 2024

Conditions
Cardiovascular Diseases
Trial Locations (2)

Unknown

University of Cape Town, Cape Town

Infectious Diseases Institute, Kampala

All Listed Sponsors
lead

University of Liverpool

OTHER

NCT03512080 - Warfarin Anticoagulation in Patients in Sub-Saharan Africa | Biotech Hunter | Biotech Hunter